Navigation Links
Anthera Pharmaceuticals Announces Notice of Allowance of U.S. Patent Application Covering A-002 Plus Statin Compositions
Date:9/8/2011

b is a potent oral inhibitor of a number of pro-inflammatory enzymes collectively known as secretory phospholipase A2 (sPLA2). Elevated levels of sPLA2 have been implicated in a variety of acute inflammatory conditions, including ACS and acute chest syndrome, as well as chronic diseases, such as stable coronary artery disease (CAD). In Anthera's FRANCIS Phase 2 clinical study in ACS patients, treatment with varespladib improved independent markers of cardiovascular risk including C-reactive protein, IL-6, LDL-C and varespladib's target enzyme, sPLA2. Recent analysis of data from diabetic patients in the same Phase 2 study demonstrated treatment with varespladib was associated with early and statistically significant reductions in these prognostic inflammatory markers of cardiovascular risk. VISTA-16 is an event driven clinical study evaluating the use of varespladib methyl in combination with Lipitor (atorvastatin calcium) to reduce secondary Major Adverse Cardiovascular Events in patients who have recently experienced an Acute Coronary Syndrome. In February 2010, Anthera received a SPA from the U.S. FDA for the VISTA-16 Phase 3 study for the use of varespladib in treating high-risk ACS patients.

About Anthera Pharmaceuticals

Anthera Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing products to treat serious diseases associated with inflammation, including cardiovascular and autoimmune diseases. Anthera has three late stage clinical products: varespladib methyl (A-002), A-001 and blisibimod (A-623). Varespladib methyl (A-002) and A-001 are designed to inhibit a novel enzyme target known as secretory phospholipase A2 (sPLA2). Elevated levels of sPLA2 have been implicated in a variety of acute inflammatory conditions, including acute coronary syndrome and acute chest syndrome, as well as chronic diseases such as stable coronary artery disease. Blisibimod targets elevated levels of B-lymphocyte stimulator (BAFF) whic
'/>"/>

SOURCE Anthera Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Anthera Pharmaceuticals Reports 2011 Second Quarter Financial Results and Operational Update
2. Anthera Pharmaceuticals Announces Completion of Public Offering of Common Stock
3. Anthera Pharmaceuticals Announces Pricing of Public Offering of Common Stock
4. Anthera Pharmaceuticals Reports 2011 First Quarter Financial Results and Operational Update
5. Anthera Pharmaceuticals Successfully Completes Interim Biomarker Analysis of VISTA-16 Study and Third Safety Review of Varespladib Methyl
6. Anthera Announces Conference Call to Discuss Analytical Method and Timing of Upcoming VISTA-16 Biomarker Analysis
7. Anthera Pharmaceuticals Names Lawrence Rosania as Vice President of Global Regulatory Affairs and Compliance
8. Dr. Peter Thompson Joins Anthera Pharmaceuticals Board of Directors
9. Anthera Pharmaceuticals Selects the Merck BioManufacturing Network as Manufacturing Supplier for A-623, Antheras Investigational Novel Peptibody Agent
10. Anthera Announces Update Call Regarding Vial Problems
11. Anthera Pharmaceuticals Reports 2010 Third Quarter Financial Results and Operational Update
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... July 22, 2014 Galmed Pharmaceuticals Ltd. (Nasdaq: ... focused on the development and commercialization of a once-daily, ... cholesterol gallstones, announced today that the U.S. Food and ... Drug, or IND, application.  Such clearance will permit Galmed ... in the United States for ...
(Date:7/22/2014)... a privately-held medical products and technologies company, today announced ... financial officer of the company, effective July 22, 2014. ... and chief financial officer of Elan Corporation, a ... part of a senior team that helped build significant ... Perrigo, a pharmaceutical manufacturer, in December 2013. ...
(Date:7/22/2014)... , July 22, 2014  According to the American ... children spend on digital devices. An AOA survey reports ... 10 and 17 estimate they use an electronic device ... separate AOA survey of parents revealed that only 40 ... device for that same amount of time. Eye doctors ...
Breaking Medicine Technology:Galmed Announces FDA Clearance of IND of Armachol for the Treatment of Fatty Liver Disorders 2Galmed Announces FDA Clearance of IND of Armachol for the Treatment of Fatty Liver Disorders 3Galmed Announces FDA Clearance of IND of Armachol for the Treatment of Fatty Liver Disorders 4ConvaTec Names Nigel Clerkin Chief Financial Officer 2Survey Reveals Parents Drastically Underestimate the Time Kids Spend on Electronic Devices 2Survey Reveals Parents Drastically Underestimate the Time Kids Spend on Electronic Devices 3Survey Reveals Parents Drastically Underestimate the Time Kids Spend on Electronic Devices 4
(Date:7/22/2014)... July 22, 2014 Dimension One Spas’ ... 24 months on all models during the “Let’s Take ... Please visit http://www.d1spas.com/financing for more information and ... Dimension One Spas offers a wide variety of outdoor ... lights, fountains, waterfalls, music, customizable massage, and personal controls. ...
(Date:7/22/2014)... July 22, 2014 Over the ... almost every sphere of human anatomy. In the ... advancements that rendered the possibility of deploying certain ... blood and tissues, in order to detect the ... abnormality. Essentially, In-vitro Diagnostics (IVD) have earned the ...
(Date:7/22/2014)... Steven Reinberg HealthDay ... Simple blood tests may one day help predict survival and ... sclerosis (ALS), also called Lou Gehrig,s disease, Italian researchers report. ... clues to how fast ALS is progressing are called albumin ... and liver health, according to the U.S. National Library of ...
(Date:7/22/2014)... of coffee and sit down to read People magazine. How ... you reach for another cup? Would you need more caffeine ... study in the Journal of Consumer Research finds ... and aspirin lose their effectiveness when they engage in more ... it takes for products to wear off. For example, they ...
(Date:7/22/2014)... an astronaut is a much-studied thing. Scientists have analyzed ... even matters of the heart. But for the first ... inflammation caused by the conditions of space flight affect ... fly on the International Space Station. Lessons learned may ... Oxidative stress reflects an imbalance in the body,s ability ...
Breaking Medicine News(10 mins):Health News:Global Molecular Diagnostics Market Report 2014 Edition Now Available at MarketReportsOnline.com 2Health News:Global Molecular Diagnostics Market Report 2014 Edition Now Available at MarketReportsOnline.com 3Health News:Global Molecular Diagnostics Market Report 2014 Edition Now Available at MarketReportsOnline.com 4Health News:Blood Test Might Help Predict Survival With Lou Gehrig's Disease 2Health News:Blood Test Might Help Predict Survival With Lou Gehrig's Disease 3Health News:Why do challenging tasks make consumers believe drugs wear off faster? 2Health News:The heart of an astronaut, five years on 2Health News:The heart of an astronaut, five years on 3
... ... Foundation has teamed up with Pilot Pen to create a line of ... Breast Cancer Foundation is a nonprofit committed to providing direct financial assistance ... early detection and survival of breast cancer. To show support Pilot Pen ...
... ... Products®, a leading direct-to-consumer provider of premium dietary supplements, announces the release of ... ... -- Purity Products®, a leading direct-to-consumer provider of premium dietary supplements, announces the ...
... Research suggests millions are going without needed medical services , ... a history of cancer, particularly people under age 65, are ... the cost of treatment, a new study suggests. , ... quality of life of the 12 million adults in the ...
... ... with the modern and hits big on iTunes store first days of launch , ... New York, NY (PRWEB) June 14, 2010 -- 2010 ... “The Karate Kid”, two events bringing renewed popular interest in Chinese martial arts. , , , ...
... ... of the dangers of cycling injuries and urges caution on the roads , ... (PRWEB) June 14, 2010 -- National Accident Helpline is urging ... weather is seeing an increasing number of people take to their bikes, often for the first ...
... ... production assets, inventory and certain information of the Cell-Pore product group previously owned and ... ... today that it has completed its purchase of the principal manufacturing and production assets, ...
Cached Medicine News:Health News:The American Breast Cancer Foundation Partners with Pilot Pen to Raise Breast Cancer Awareness Nation-Wide 2Health News:The American Breast Cancer Foundation Partners with Pilot Pen to Raise Breast Cancer Awareness Nation-Wide 3Health News:Purity Products Releases Ultimate Sleep Plus Melatonin 2Health News:Cost-Conscious Cancer Survivors Skip Care 2Health News:Cost-Conscious Cancer Survivors Skip Care 3Health News:New iPhone App “Wing Chun Masters” Brings 400-Year-Old Kung Fu To Life Amidst Renewed Popular Interest In Culture. 2Health News:New iPhone App “Wing Chun Masters” Brings 400-Year-Old Kung Fu To Life Amidst Renewed Popular Interest In Culture. 3Health News:Break The Injury Cycle, Says National Accident Helpline 2Health News:CerMedia Completes Purchase of Cell-Pore Principal Assets from NanoDynamics 2